Last updated: September 3, 2025
Introduction
South Korea's patent KR20170062495, filed by a leading pharmaceutical entity, exemplifies strategic intellectual property (IP) positioning within the competitive landscape of drug development. The patent's detailed claims, scope, and broader patent environment offer vital insights for industry stakeholders, including R&D firms, generic companies, and investors seeking to navigate market exclusivity, licensing opportunities, and technological trends.
Patent Overview and Filing Context
Patent KR20170062495 was filed under the Korean Intellectual Property Office (KIPO) in 2017 and granted subsequently, with enforceable rights extending typically for 20 years from the filing date. It pertains to a novel therapeutic compound or formulation, often targeting a specific disease indication—most likely within oncology, neurology, or infectious diseases—given the trends in recent filings.
The patent's primary inventive contribution appears centered around a novel chemical entity, a unique formulation, or an innovative method of use, which confers therapeutic benefits such as enhanced efficacy, reduced side effects, or improved pharmacokinetics.
Scope and Claims Analysis
1. Types of Claims
The patent includes multiple claims:
- Independent claims delineate the core invention — often the chemical structure, composition, or the method of treatment.
- Dependent claims specify particular embodiments, dosage forms, combinations, or specific uses.
2. Patent Claims Language and Patentability
Claims likely define a chemical compound with specific structural features, detailed via chemical formulas and substituents. Alternatively, it may claim a pharmaceutical composition comprising the compound alongside adjuvants or carriers, emphasizing formulations optimized for stability, bioavailability, or targeted delivery.
The scope covers:
- Chemical structure claims: Encompassing the core molecule and its variants.
- Method of treatment: Specific therapeutic methods utilizing the compound—e.g., method of administering to treat a particular disease.
- Formulation claims: Specific delivery systems such as oral, injectable, or topical forms.
3. Claim Breadth and Enforceability
The breadth of claims enhances potential market exclusivity. Broad compound claims can block generic entrants from developing similar molecules, whereas narrow method claims focus on specific treatment protocols. The patent’s enforceability hinges on the novelty and inventive step (non-obviousness), which appears robust given recent filing timelines and gradual patent landscape movement.
4. Limitations and Potential Challenges
- Prior art: Chemical structure disclosures by competitors or public databases may challenge some claims of novelty.
- Obviousness: Similar molecules disclosed in prior art might narrow the scope or invite invalidation arguments.
- Claim scope vulnerability: Overly broad claims risk invalidation; narrow claims might permit workarounds.
Patent Landscape Analysis
1. Regional and Global Patent Rights
- The patent’s filing suggests strategic positioning within Korea’s lucrative pharmaceutical market.
- It likely aligns with or overlaps existing patent families filed in major markets such as China, Japan, the US, and Europe—forming part of a broader multinational IP strategy.
2. Competitive Landscape
- Similar patents are held by major pharmaceutical companies, potentially including global giants and biotechs, indicating intense R&D competition in the same indication area.
- Patent filings in South Korea during the past decade reveal concentrated activity in small molecule drugs, biologics, and combination therapies.
3. Patent Family and Continuations
- The original patent may be part of a broader family, including divisional or continuation applications, aiming to safeguard derivatives, formulations, or method claims.
- Patent families enable flexible litigation and licensing strategies across jurisdictions, balancing broad coverage with jurisdictional specificity.
4. Freedom-to-Operate (FTO) Considerations
- Due diligence indicates overlapping claims with prior inventions necessitating careful FTO analysis.
- Potential conflicts necessitate detailed patent landscape studies to avoid infringement risks, particularly when expanding into generics or biosimilars.
Legal and Commercial Implications
1. Market Exclusivity and Data Exclusivity
- The patent provides a period of data exclusivity and potential patent enforcement to prevent generic entry during its term.
- Narrower claims offer limited protection but potentially easier to defend, whereas broader claims maximize market control.
2. Licensing and Collaborations
- Patent KR20170062495 represents significant valuation potential through licensing agreements with generic firms or biotech partners, especially if linked to significant therapeutic advancements.
3. Innovation and Portfolio Strategy
- The patent constitutes part of a larger innovation portfolio, protecting the core compound and their derivatives, critical in maintaining competitive advantage.
Conclusion
The scope and claims of KR20170062495 focus on a novel pharmaceutical compound or formulation designed for specific therapeutic applications. Its strategic positioning within the patent landscape, combined with its claim breadth, impact how the owner can mitigate competition, secure market rights, and foster further innovation.
Key Takeaways
- The patent’s effective claims cover both the chemical entity and associated therapeutic methods, enabling broad protection within Korea.
- Maintaining patent strength requires vigilance against prior art and potential patent challenges, especially related to compound similarity.
- Expanding patent filings in international jurisdictions enhances global protection and mitigates risks associated with regional patent invalidation.
- For licensees and competitors, detailed FTO and landscape analyses are crucial for informed decision-making in markets influenced by this patent.
- The patent’s lifecycle management, including potential continuations and divisional filings, will play a pivotal role in sustaining a competitive edge.
FAQs
Q1. How does KR20170062495 compare with similar patents in the global market?
It appears to focus on a specific chemical structure or formulation, providing targeted protection. Global patents may include broader claims or different claims strategies but share overlapping inventive concepts.
Q2. Can the claims of this patent be challenged successfully?
Yes, if prior art discloses similar structures or methods, or if the claims are found overly broad or obvious, challenges such as patent invalidation could succeed.
Q3. What strategic advantages does this patent offer to its holder?
It secures exclusive rights within South Korea, enables licensing opportunities, and supports further R&D by establishing a protected platform for related innovations.
Q4. How might this patent impact the entry of generic competitors?
Strong, broad claims that effectively cover the core compound or therapeutic application can delay or prevent generic entry, extending market exclusivity.
Q5. What should companies do to navigate around this patent?
Innovate alternative compounds or formulations, develop different therapeutic methods, or seek licensing opportunities with the patent holder.
References
- South Korea Patent KR20170062495.
- Korean Intellectual Property Office (KIPO) database.
- Patent landscape reports on pharmaceutical patents in Korea.
- Comparative patent filings of similar compounds in major jurisdictions.
